X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Divis Laboratories with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs LUPIN LTD - Comparison Results

DIVIS LABORATORIES    Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES LUPIN LTD DIVIS LABORATORIES/
LUPIN LTD
 
P/E (TTM) x 31.1 22.7 137.3% View Chart
P/BV x 5.4 3.1 175.5% View Chart
Dividend Yield % 0.9 0.8 112.7%  

Financials

 DIVIS LABORATORIES   LUPIN LTD
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-17
LUPIN LTD
Mar-17
DIVIS LABORATORIES/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs1,2221,750 69.8%   
Low Rs7841,384 56.7%   
Sales per share (Unadj.) Rs153.1387.4 39.5%  
Earnings per share (Unadj.) Rs39.956.6 70.5%  
Cash flow per share (Unadj.) Rs44.676.8 58.0%  
Dividends per share (Unadj.) Rs10.007.50 133.3%  
Dividend yield (eoy) %1.00.5 208.3%  
Book value per share (Unadj.) Rs201.8298.9 67.5%  
Shares outstanding (eoy) m265.47451.58 58.8%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x6.64.0 162.0%   
Avg P/E ratio x25.127.7 90.8%  
P/CF ratio (eoy) x22.520.4 110.3%  
Price / Book Value ratio x5.05.2 94.8%  
Dividend payout %25.013.2 189.0%   
Avg Mkt Cap Rs m266,266707,513 37.6%   
No. of employees `0009.716.8 58.0%   
Total wages/salary Rs m4,68728,495 16.4%   
Avg. sales/employee Rs Th4,175.010,418.3 40.1%   
Avg. wages/employee Rs Th481.51,697.0 28.4%   
Avg. net profit/employee Rs Th1,089.31,523.0 71.5%   
INCOME DATA
Net Sales Rs m40,643174,943 23.2%  
Other income Rs m7491,065 70.3%   
Total revenues Rs m41,392176,008 23.5%   
Gross profit Rs m14,46044,931 32.2%  
Depreciation Rs m1,2339,122 13.5%   
Interest Rs m231,525 1.5%   
Profit before tax Rs m13,95335,349 39.5%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,3499,785 34.2%   
Profit after tax Rs m10,60425,575 41.5%  
Gross profit margin %35.625.7 138.5%  
Effective tax rate %24.027.7 86.7%   
Net profit margin %26.114.6 178.5%  
BALANCE SHEET DATA
Current assets Rs m40,105119,542 33.5%   
Current liabilities Rs m6,59561,206 10.8%   
Net working cap to sales %82.533.3 247.3%  
Current ratio x6.12.0 311.4%  
Inventory Days Days11976 156.0%  
Debtors Days Days8190 89.8%  
Net fixed assets Rs m19,995131,660 15.2%   
Share capital Rs m531903 58.8%   
"Free" reserves Rs m53,043134,073 39.6%   
Net worth Rs m53,574134,976 39.7%   
Long term debt Rs m056,478 0.0%   
Total assets Rs m61,585266,073 23.1%  
Interest coverage x618.424.2 2,558.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.70.7 100.4%   
Return on assets %17.310.2 169.4%  
Return on equity %19.818.9 104.5%  
Return on capital %26.119.3 135.4%  
Exports to sales %00-   
Imports to sales %25.20-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m10,259NA-   
Fx inflow Rs m35,38481,885 43.2%   
Fx outflow Rs m10,39921,506 48.4%   
Net fx Rs m24,98560,378 41.4%   
CASH FLOW
From Operations Rs m11,49341,148 27.9%  
From Investments Rs m-11,372-25,287 45.0%  
From Financial Activity Rs m-934,332 -2.1%  
Net Cashflow Rs m2820,193 0.1%  

Share Holding

Indian Promoters % 52.0 46.6 111.6%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 11.8 11.3 104.4%  
FIIs % 19.0 31.9 59.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 10.1 170.3%  
Shareholders   31,796 98,259 32.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   MERCK LTD  STERLING BIOTECH  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  IPCA LABS  

Compare DIVIS LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Sensex Touching Record Highs, Rally in Banking Stocks and Key Stocks in Action Today(Pre-Open)

BSE Sensex is on a roll. The index touched a record high of 35,000 on Wednesday and further inched upwards to end yesterday's trade at a level of 35,260.

Related Views on News

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Jan 18, 2018 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - MERCK LTD COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS